Vertebroplasty - percutaneous cement augmentation of vertebral bodies - is
an efficient procedure for the treatment of painful vertebral fractures in
osteoporosis. At the present time, polymethylmethacrylate (PMMA) is the onl
y available cement with reports of clinical application and experience. The
material is easy to handle, the radiopacity can be adapted by adding contr
ast dye, and it is mechanically efficient. Composite cements (acrylic cemen
ts in conjunction with ceramics) are bioactive, highly radiopaque, and feat
ure excellent mechanical properties. One such cement, Cortoss, is currently
undergoing clinical trials for vertebroplasty and has so far been shown to
be a potentially valuable alternative to PMMA. Several in vitro studies wi
th injectable calcium phosphate (CaP) cements show their feasibility and me
chanical effectiveness. Animal studies confirm their biocompatibility and o
steoconductivity. However, handling problems and the limited radiopacity of
these cements currently preclude their clinical use.